Pharmacokinetics and Metabolism of [14C] BMS-986231 in Healthy Male Participants
Latest Information Update: 04 Aug 2017
Price :
$35 *
At a glance
- Drugs Cimlanod (Primary)
- Indications Acute heart failure
- Focus Pharmacokinetics
- Sponsors Bristol-Myers Squibb
- 28 Jul 2017 Status changed from recruiting to completed.
- 10 Jul 2017 New trial record